Since the duration of tumor IFNγ signaling and overexpression of ISG.RS accounted for the resistant to ICIs,20 21 we hypothesized that SOX2 impaired CD8+ T-cell killing through regulating the IFNγ signaling. Here, SOX2 is linked to neoplasm.